UBE2I and cancer: The same group reported that knockdown of UBC9 in BRCA1 mutant triple-negative breast cancer and HGSOC cells inhibited cell proliferation and migration, indicating the pivotal role of UBC9 in endothelial-mesenchymal transition in such cancer type [34].